Juan A. Pineda mainly focuses on Internal medicine, Hepatitis C virus, Immunology, Gastroenterology and Virology. His Internal medicine research is multidisciplinary, incorporating elements of Coinfection and Surgery. His Hepatitis C virus research is multidisciplinary, incorporating perspectives in Viral disease and Hepatitis C.
His work carried out in the field of Immunology brings together such families of science as Odds ratio, Acquired immunodeficiency syndrome and Incidence. Juan A. Pineda usually deals with Gastroenterology and limits it to topics linked to Liver biopsy and Fibrosis. His work deals with themes such as Asymptomatic and Polymerase chain reaction, which intersect with Virology.
His main research concerns Internal medicine, Hepatitis C virus, Gastroenterology, Virology and Immunology. His research in Internal medicine intersects with topics in Coinfection and Ribavirin. His Hepatitis C virus study combines topics in areas such as Liver disease, Viral load and Cohort.
The study incorporates disciplines such as Fibrosis, Pathology, Liver biopsy and Confidence interval in addition to Gastroenterology. The Virology study combines topics in areas such as Antibody, Serology, Allele and Genotype. His Immunology research includes themes of Odds ratio and Acquired immunodeficiency syndrome.
Juan A. Pineda focuses on Internal medicine, Hepatitis C virus, Gastroenterology, Hepatitis C and Cirrhosis. Internal medicine and Coinfection are frequently intertwined in his study. Hepatitis C virus is a subfield of Virology that Juan A. Pineda investigates.
His study in Gastroenterology is interdisciplinary in nature, drawing from both Prospective cohort study and Propensity score matching. Juan A. Pineda has researched Hepatitis C in several fields, including Ribavirin, Sofosbuvir and Health policy. His studies in Cirrhosis integrate themes in fields like Clinical endpoint and Genotype.
Juan A. Pineda mostly deals with Internal medicine, Hepatitis C virus, Gastroenterology, Hepatitis C and Cirrhosis. His Internal medicine research incorporates themes from Tenofovir alafenamide, Ribavirin and Cobicistat. His research integrates issues of Drug, Epidemiology and Genotype in his study of Hepatitis C virus.
Juan A. Pineda studies Gastroenterology, focusing on Bilirubin in particular. As part of the same scientific family, Juan A. Pineda usually focuses on Hepatitis C, concentrating on Sofosbuvir and intersecting with Viral hepatitis. His Cirrhosis research is multidisciplinary, incorporating elements of Retrospective cohort study, Confidence interval, Hepatocellular carcinoma, Albumin and Coinfection.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
HIV coinfection shortens the survival of patients with hepatitis C virus‐related decompensated cirrhosis
Juan A. Pineda;Manuel Romero-Gómez;Fernando Díaz-García;José A. Girón-González.
Fast fibrosis progression between repeated liver biopsies in patients coinfected with human immunodeficiency virus/hepatitis C virus.
Juan Macías;Juan Berenguer;Miguel A. Japón;José A. Girón.
Clinical progression of hepatitis C virus–related chronic liver disease in human immunodeficiency virus–infected patients undergoing highly active antiretroviral therapy
Juan A. Pineda;José A. García-García;Manuela Aguilar-Guisado;María J. Ríos-Villegas.
The Use of Transient Elastometry for Assessing Liver Fibrosis in Patients with HIV and Hepatitis C Virus Coinfection
Salvador Vergara;Juan Macías;Antonio Rivero;Alicia Gutiérrez-Valencia.
Clinical Infectious Diseases (2007)
Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease.
Nicolás Merchante;José A Girón-González;Mercedes González-Serrano;Julian Torre-Cisneros.
Effect of antiretroviral drugs on liver fibrosis in HIV-infected patients with chronic hepatitis C: harmful impact of nevirapine.
Juan Macías;Victor Castellano;Nicolás Merchante;Rosa B Palacios.
Prevalence of genotypic resistance to nucleoside analogues in antiretroviral-naive and antiretroviral-experienced HIV-infected patients in Spain.
María Gómez-Cano;Amalia Rubio;Teresa Puig;Mayte Pérez-Olmeda.
Prediction of Response to Pegylated Interferon plus Ribavirin by IL28B Gene Variation in Patients Coinfected with HIV and Hepatitis C Virus
Juan A. Pineda;Antonio Caruz;Antonio Rivero;Karin Neukam.
Clinical Infectious Diseases (2010)
Liver toxicity induced by non-nucleoside reverse transcriptase inhibitors
Antonio Rivero;José A. Mira;Juan A. Pineda.
Journal of Antimicrobial Chemotherapy (2007)
Low response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C treated with abacavir.
Eugenia Vispo;Pablo Barreiro;Juan A Pineda;José A Mira.
Antiviral Therapy (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: